Expiring drug patents to plunge

As sources to copy dry up, makers of generics look to redefine themselves

Posted: December 23, 2012 at 2:36 a.m.

A lab technician works with sterile products during drug manufacturing at a plant owned by Teva Pharmaceuticals Industries Ltd.’s factory in Godollo, Hungary, in October. Teva is the world’s largest maker of generic drugs.

They call it the patent cliff. Brand-name drugmakers have feared it for years. And now generic-drug makers fear it, too.

This story is only available from our archives.

Business, Pages 67 on 12/23/2012